
    
      we entered 150 eyes into the study that recruitment of cases finished recently.Eligible eyes
      randomly assign to one of the study arms including intravitreal bevacizumzb, intravitreal
      bevacizumzb/triamcinolone and macular photocoagulation groups. Every patient needs at least 1
      year followup. During this time BCVA, OCT, FA will be done for each patient and inaccording
      to interpretation of datas and fundus exam repeatation of injection will be done.
    
  